BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1029 related articles for article (PubMed ID: 18711108)

  • 1. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
    Bigal ME; Serrano D; Reed M; Lipton RB
    Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute treatment of episodic and chronic migraine in the USA.
    Bigal ME; Borucho S; Serrano D; Lipton RB
    Cephalalgia; 2009 Aug; 29(8):891-7. PubMed ID: 19222509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarities and differences between chronic migraine and episodic migraine.
    Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
    Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.
    Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P
    Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
    Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
    Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
    Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries.
    Morillo LE; Alarcon F; Aranaga N; Aulet S; Chapman E; Conterno L; Estevez E; Garcia-Pedroza F; Garrido J; Macias-Islas M; Monzillo P; Nunez L; Plascencia N; Rodriguez C; Takeuchi Y;
    Headache; 2005 Feb; 45(2):118-26. PubMed ID: 15705116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Serrano D; Buse DC; Manack Adams A; Reed ML; Lipton RB
    Headache; 2015 Apr; 55(4):502-18. PubMed ID: 25881676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.
    Diamond S; Bigal ME; Silberstein S; Loder E; Reed M; Lipton RB
    Headache; 2007 Mar; 47(3):355-63. PubMed ID: 17371352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-traumatic stress disorder in episodic and chronic migraine.
    Peterlin BL; Tietjen G; Meng S; Lidicker J; Bigal M
    Headache; 2008 Apr; 48(4):517-22. PubMed ID: 18377377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and medication preferences of individuals with headache presenting to a community pharmacy.
    Wenzel RG; Schommer JC; Marks TG
    Headache; 2004 Jan; 44(1):90-4. PubMed ID: 14979890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pivotal moment in 50 years of headache history: the first American Migraine Study.
    Tepper SJ
    Headache; 2008 May; 48(5):730-1; discussion 732. PubMed ID: 18471125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the utility of in-clinic "rescue" therapy for acute migraine.
    Morey V; Rothrock JF
    Headache; 2008 Jun; 48(6):939-43. PubMed ID: 18549372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine days decline with duration of illness in adolescents with transformed migraine.
    Bigal ME; Sheftell FD; Tepper SJ; Rapoport AM; Lipton RB
    Cephalalgia; 2005 Jul; 25(7):482-7. PubMed ID: 15955034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The migraine cycle: patient burden of migraine during and between migraine attacks.
    Brandes JL
    Headache; 2008 Mar; 48(3):430-41. PubMed ID: 18179565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field testing alternative criteria for chronic migraine.
    Bigal ME; Tepper SJ; Sheftell FD; Rapoport AM; Lipton RB
    Cephalalgia; 2006 Apr; 26(4):477-82. PubMed ID: 16556250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.